Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Shuaibing Ying"'
Autor:
Yaqiong Zhan, Lushun Jiang, Xuehang Jin, Shuaibing Ying, Zhe Wu, Li Wang, Wei Yu, Jiepeng Tong, Li Zhang, Yan Lou, Yunqing Qiu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110996- (2021)
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients. RRM2 mediates the resistance of many chemother
Externí odkaz:
https://doaj.org/article/e948f89f19d045f4a6eb6ae82f490767
Autor:
Yingsha Chen, Shuaibing Ying, Lushun Jiang, Shaohua Dong, Jinyao Dai, Xuehang Jin, Wei Yu, Yunqing Qiu
Publikováno v:
Infection and Drug Resistance. 15:1317-1328
Yingsha Chen,1,2 Shuaibing Ying,1 Lushun Jiang,1 Shaohua Dong,1 Jinyao Dai,1 Xuehang Jin,1 Wei Yu,1 Yunqing Qiu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Coll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d611ec58674cda49821d7e0fd594f46
https://doi.org/10.2147/idr.s349236
https://doi.org/10.2147/idr.s349236
Autor:
Wei Yu, Li Zhang, Jiepeng Tong, Shuaibing Ying, Xuehang Jin, Hao Xu, Yunqing Qiu, Yiheng Jiang
Publikováno v:
Drug Design, Development and Therapy
Jiepeng Tong,1 Yiheng Jiang,2 Hao Xu,1 Xuehang Jin,1 Li Zhang,1 Shuaibing Ying,1 Wei Yu,1 Yunqing Qiu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127941d844e3dd82e4f73c864632cb58
https://doi.org/10.2147/dddt.s315061
https://doi.org/10.2147/dddt.s315061
Autor:
Yingsha, Chen, Shuaibing, Ying, Lushun, Jiang, Shaohua, Dong, Jinyao, Dai, Xuehang, Jin, Wei, Yu, Yunqing, Qiu
Publikováno v:
Infection and drug resistance. 15
Our study aimed to explore the risk factors in bloodstream infectionsA total of 252 BSI-KP patients were enrolled from a tertiary teaching hospital between January 1, 2015, and May 31, 2020. Risk factors associated with BSI-CRKP and factors associate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd9c15bab58f199e8b8720483ee0c93f
https://pubmed.ncbi.nlm.nih.gov/35378894
https://pubmed.ncbi.nlm.nih.gov/35378894
Publikováno v:
Infection and Drug Resistance.
Jiajie Zhang,1 Yicheng Huang,1 Hao Xu,2 Shuaibing Ying,2 Hongying Pan,1 Wei Yu2 1Department of Infectious Diseases, Zhejiang Provincial Peopleâs Hospital, Peopleâs Hospital of Hangzhou Medical College, Hangzhou, Peopleâs Republic of Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2972435ced81eda7506278280a3611c4
https://www.dovepress.com/genomic-and-phenotypic-characteristics-for-vibrio-vulnificus-infection-peer-reviewed-fulltext-article-IDR
https://www.dovepress.com/genomic-and-phenotypic-characteristics-for-vibrio-vulnificus-infection-peer-reviewed-fulltext-article-IDR
Autor:
Shuaibing Ying, Xuehang Jin, Yan Lou, Lushun Jiang, Zhe Wu, Yaqiong Zhan, Yunqing Qiu, Jiepeng Tong, Li Wang, Wei Yu, Li Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 133, Iss, Pp 110996-(2021)
RRM2, the small subunit of ribonucleotide reductase, is identified as a tumor promotor and therapeutic target. It is common to see the overexpression of RRM2 in chemo-resistant cancer cells and patients. RRM2 mediates the resistance of many chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748827c3bf635ab04955af70a6c910cd
https://pubmed.ncbi.nlm.nih.gov/33227712
https://pubmed.ncbi.nlm.nih.gov/33227712